These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39069033)

  • 41. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
    Wu Z; Chen B; Gan Z; Chen F; Luo X
    Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
    Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
    Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
    Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
    Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy.
    Qiao L; Yuan X; Peng H; Shan G; Gao M; Yi X; He X
    Drug Deliv; 2021 Dec; 28(1):2218-2228. PubMed ID: 34668829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
    Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery.
    Bae Y; Kim Y; Lee ES
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34200716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo.
    Fernandes RS; Silva JO; Seabra HA; Oliveira MS; Carregal VM; Vilela JMC; Andrade MS; Townsend DM; Colletti PM; Leite EA; Cardoso VN; Ferreira LAM; Rubello D; Barros ALB
    Biomed Pharmacother; 2018 Jul; 103():1348-1354. PubMed ID: 29864917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization.
    Rangasami VK; Samanta S; Parihar VS; Asawa K; Zhu K; Varghese OP; Teramura Y; Nilsson B; Hilborn J; Harris RA; Oommen OP
    Carbohydr Polym; 2021 Feb; 254():117291. PubMed ID: 33357860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Na
    Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
    Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-α-tocopheryl polyethylene glycol succinate.
    Liu Y; Wu J; Huang L; Qiao J; Wang N; Yu D; Zhang G; Yu S; Guan Q
    Int J Biol Macromol; 2020 Jul; 154():499-510. PubMed ID: 32194114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ROS-Responsive Nanoprobes for Bimodal Imaging-Guided Cancer Targeted Combinatorial Therapy.
    Jiang F; Liu S; Wang L; Chen H; Huang Y; Cao Y; Wang X; Lin M; Zhang J
    Int J Nanomedicine; 2024; 19():8071-8090. PubMed ID: 39130685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery.
    Qiu L; Zhu M; Gong K; Peng H; Ge L; Zhao L; Chen J
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():912-922. PubMed ID: 28576067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.